Gilead Sciences
AGREEMENT GRADE
f
Fortune 500 Rank (2018)
116
OWLER CEO APPROVAL RATING
53/100
GLASSDOOR RATING
3.1/5
CEO
John F. Milligan
Gilead Sciences, Inc. is an American biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi. Headquartered and founded in Foster City, California, Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.
AG Sources
Clark has filed this declaratory judgment action against Schinazi asking the court to declare an arbitration provision entered into between he and Pharmasset, Inc. (“Pharmasset”), which Schinazi signed on behalf of Pharmasset, to be void and unenforceable. -Clark v. Shinazi (2010)
Links